Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease

J Neuropsychiatry Clin Neurosci. 2015 Winter;27(1):e90. doi: 10.1176/appi.neuropsych.14010015.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Cholinesterase Inhibitors / therapeutic use*
  • Delirium / drug therapy*
  • Delirium / etiology
  • Electroconvulsive Therapy / adverse effects
  • Female
  • Humans
  • Middle Aged
  • Parkinson Disease / therapy
  • Phenylcarbamates / therapeutic use*
  • Rivastigmine
  • Schizophrenia, Paranoid / drug therapy*
  • Schizophrenia, Paranoid / etiology

Substances

  • Cholinesterase Inhibitors
  • Phenylcarbamates
  • Rivastigmine